Programa

Scientific Committee

El Comité Científico tiene la responsabilidad de desarrollar un programa científico riguroso y relevante que refleje las últimas innovaciones, garantice los más altos estándares de excelencia, represente a la membresía internacional de la sociedad, fomente un intercambio intelectual significativo y aborde los desafíos globales relevantes para el campo.

Dra. Marianne Abi

MARIANNE
ABIFADEL
Chair - Lebanon

Dr. Arnold von Eckardstein

ARNOLD VON
ECKARDSTEIN
Switzerland

Dra. Catalina Fuentes

CATALINA
FUENTES
Chile

Dra. María Cristina Izar

CHRISTINA
IZAR
Brazil

Dr. Brett Mansfield

BRETT
MANSFIELD
South Africa

Dra. Roopa Mehta

ROOPA
MEHTA
Mexico

Dra. Jessica Peña

JESSICA
PEÑA
The United States

Dr. Raul Santos

RAÚL
SANTOS
Co-Chair - Brazil

Dra. Mariko Shiba

MARIKO
SHIBA
Japan

Dra. Lale Tokgozoglu

LALE
TOKGÖZOĞLU
Türkiye

Dr. Salim Virani

SALIM
VIRANI
Pakistan

Dr. Gerald Watts

GERALD
WATTS
Australia

Dr. Fernando Wyss

FERNANDO
WYSS
Guatemala

Scientific Program

ISA 2027 will feature a high-level scientific program, currently being organized by a distinguished international committee. A call for proposals for sessions, including joint sessions, will be issued shortly. The participation of the Society’s global membership is essential to shaping this unique scientific gathering in Latin America

More information comming soon

Abstracts

Information regarding abstract submissions for ISA 2027 will be announced soon. This call will provide authors from around the world the opportunity to share advancements, updates, and clinical cases related to atherosclerosis and cardiometabolic health.

More information

Main Topics

While the scientific program is currently under development, the core pillars of ISA 2027 will focus on the genetics of atherosclerosis, innovations in lipidology, and the global clinical impact of cardiometabolic health.

• Artificial Intelligence 
• Atherosclerosis & CVD 
• CKM Syndrome
• Diabetes
• Digital Health 
• Equity & Access 
• Genetic Lipid Disorders 
• Genetics & Gene Editing 
• Guideline Implementation 
• Health Economics 
• Hypertriglyceridemia 
• Imaging & Diagnostic Advancements 
• Inflammation & Vascular Biology 

• Longevity 
• Misinformation in Medicine 
• Novel Lipid Medications 
• Nutrition 
• MASLD 
• Obesity 
• Patient Engagement 
• Precision Medicine & Omics 
• Public Policy 
• Risk Assessment Tools 
• Sleep Apnea 
• Women’s Health 

Stay updated on ISA 2027

Subscribe to receive information about the scientific program, the call for abstracts, travel grants and more